Zyclara (imiquimod) - Mochida, Viatris, Bausch Health
Evaluation of anti-psoriatic activity, mechanistic insights, nanoformulation, and GC-MS profiling of Commiphora gileadensis essential oil. (PubMed, Artif Cells Nanomed Biotechnol) - Oct 19, 2026 - "Nanoemulgel formulations of the oil (Eg: 0.25%, 0.5%, and 1% w/w) were evaluated in an imiquimod (IMQ)-induced psoriasis-like model in BALB/c mice...It attenuated tissue pyroptosis and restored cellular autophagy, supported by histopathology and reduced Ki67 expression. These findings highlight nanoemulgel of C. gileadensis essential oil as a potential therapy to alleviate psoriasis." 
Journal • Dermatology • Immunology • Inflammation • Psoriasis • IL17A • IL18 • IL1B • IL23A
http://www.ncbi.nlm.nih.gov/pubmed/42891983
 
Asmaa A Ahmed; Elsayed K El-Sayed; Eman G Haggag; Fatma M Abdel Bar; Fawaz K Alanazi; Mohamed I S Abdelhady; Nadeem Ahmed; Nashwa Hashad
 
Oct 19, 2026
 
Prev Next